Navigation Links
New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Date:2/20/2013

ative risk reduction 46 percent; p<0.001)
  • Trend toward lower risk of major bleeding alone: 13 patients, 0.9 percent versus 25 patients,1.8 percent (relative risk reduction 48 percent; p=0.06)
  • A higher rate of acute coronary syndrome (ACS) events was observed in the dabigatran group versus warfarin (13 patients, 0.9 percent versus three patients, 0.2 percent, respectively; p=0.02)
  • RE-SONATE

    • Design: 1,343 patients randomized to dabigatran 150 mg (681 patients) or placebo (662 patients) for six months with extended follow-up to evaluate the long-term risk of recurrence (12 months after completion of study treatment)
    • Efficacy: 92 percent risk reduction for recurrent or fatal VTE with dabigatran versus placebo (three patients, 0.4 percent versus 37 patients, 5.6 percent; p<0.001 for superiority)
    • Safety: the incidence of major bleeding was two patients in the dabigatran group versus zero patients in the placebo group. A higher rate of major or clinically relevant bleeding in the dabigatran group versus no treatment was observed (36 patients, 5.3 percent versus 12 patients, 1.8 percent; p=0.001)

    * Pradaxa® (dabigatran etexilate mesylate) capsules are not approved by the U.S. Food and Drug Administration for the prevention of recurrent VTE or the treatment of acute VTE.

    About Pradaxa® (dabigatran etexilate mesylate) Capsules

    Indications and Usage
    Pradaxa® (dabigatran etexilate mesylate) capsules is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

    IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

    CONTRAINDICATIONS
    PRADAXA is contraindicated in patients with:

    • Active pathological bleeding
    • A known serious hypersensitivity rea
      '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
    3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
    4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
    5. Shingles Vaccine is Safe, According to New Study
    6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
    7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
    11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/3/2015)... YORK , July 3, 2015  Obsidian HDS, ... - an online service for the management of data ... announced today that PharmaShine now includes the 2014 Open ... for Medicare Services on June 30. The data disclosed ... million transactions between industry and providers totaling $6.49 billion ...
    (Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
    (Date:7/2/2015)... , July 2, 2015 Leading ... to capture critical product and market insights in ... benefits to employee-based studies, it is essential for ... own internal employees to capture critical business-related insights. ... benchmarking firm, Best Practices, LLC, most benchmarked companies ...
    Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2
    ... Systems, Inc. (OTCBB: OXYS) ("OxySure"), the pioneering manufacturer ... "oxygen from powder" technology has announced the Company ... W.W. Grainger, Inc. (NYSE: GWW ) ... In terms of the Agreement, OxySure will ...
    ... GREENWICH, Conn., March 15, 2012 Timothy C. Tyson, ... has been named President and Chief Operating Officer of ... Clinical Trials Supply Business, Mr. Needleman has been promoted ... Operations. In his new role, Mr. Needleman is responsible ...
    Cached Medicine Technology:OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer 2
    (Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part ... to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the ... , Almost every smartphone has an incredibly powerful camera built into it. And when ...
    (Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... located in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... opened June 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will ... Amica Insurance is sharing some tips to promote the proper use of ... go to the emergency room daily with fireworks-related injuries in the month surrounding the ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
    (Date:7/2/2015)... N.J. (PRWEB) , ... July 02, 2015 , ... ... ACO and Emerging Healthcare Delivery Coalition met for the late June Web-based session, ... forward with new reimbursement schemes and managing high-risk patients through coordinated care. , ...
    Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4
    ... persons in the Shangdong province of eastern China have been ... has since been contained, state news agency Xinhua has ... last and another 393 people mostly children were ... the agency said, citing Bao Wenhui, the deputy director of ...
    ... do not completely control epilepsy, surgery often can, and the ... epilepsy specialists are struggling to get that message to tens ... knife at younger ages. ,Says Dr. Deborah Holder, ... be thought of as a last resort. Now we don't ...
    ... found that the male impotence drug Viagra may be ... originally developed for the treatment of high blood pressure ... reduces levels of a naturally-occurring compound, cyclic guanine monophosphate ... vital function in a signalling pathway that regulates the ...
    ... concentrated radio waves appears to be a safe and effective ... that can be a precursor of cancer . ... esophagus, a condition associated with the continued reflux of stomach ... over time. While this condition is relatively common, a small ...
    ... to completely wipe out wild relatives of plants such as ... by the Consultative Group on International Agricultural Research (CGIAR). ... as many as 61 percent of the 51 wild peanut ... species analyzed could become extinct as the result of climate ...
    ... respond favorably to the drug temozolomide when used as ... to work best in people missing a certain gene. ... the American Academy of Neurology. ,Researchers studied ... of brain tumor, who were treated with temozolomide chemotherapy ...
    Cached Medicine News:Health News:Potential Of Epilepsy Surgeries Are Not Fully Harnessed Say Brain Specialists 2Health News:New Approach to Treating Precancerous Esophagus Condition 2Health News:New Approach to Treating Precancerous Esophagus Condition 3Health News:Climate Change Threatening to Wipe Out Wild Relatives of Key Crops 2
    ... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
    ... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
    ... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
    ... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
    Medicine Products: